Haneefa T Saleem1, Dorothy Mushi2, Saria Hassan3, R Douglas Bruce4, Alexis Cooke5, Jessie Mbwambo2, Barrot H Lambdin6. 1. Pangaea Global AIDS, 436, 14th Street, Suite 920, Oakland, CA 94612, United States. Electronic address: hsaleem1@jhu.edu. 2. Muhimbili University of Health and Allied Sciences, Department of Psychiatry, P.O. Box 65293, Dar es Salaam, Tanzania. 3. Pangaea Global AIDS, 436, 14th Street, Suite 920, Oakland, CA 94612, United States. 4. Pangaea Global AIDS, 436, 14th Street, Suite 920, Oakland, CA 94612, United States; Cornell Scott-Hill Health Center, 428 Columbus Avenue, New Haven, CT 06519, United States; Yale University School of Medicine, 333 Cedar Street, New Haven, CT 06510, United States. 5. University of California, Los Angeles, Fielding School of Public Health, Department of Community Health Sciences, United States. 6. RTI International, 351 California Street, Suite 500, San Francisco, CA 94104, United States; University of California San Francisco, San Francisco, CA, United States; University of Washington, Seattle, WA, United States.
Abstract
BACKGROUND: Despite dramatic improvement in antiretroviral therapy (ART) access globally, people living with HIV who inject drugs continue to face barriers that limit their access to treatment. This paper explores barriers and facilitators to ART initiation among clients attending a methadone clinic in Dar es Salaam, Tanzania. METHODS: We interviewed 12 providers and 20 clients living with HIV at the Muhimbili National Hospital methadone clinic between January and February 2015. We purposively sampled clients based on sex and ART status and providers based on job function. To analyze interview transcripts, we adopted a content analysis approach. RESULTS: Participants identified several factors that hindered timely ART initiation for clients at the methadone clinic. These included delays in CD4 testing and receiving CD4 test results; off-site HIV clinics; stigma operating at the individual, social and institutional levels; insufficient knowledge of the benefits of early ART initiation among clients; treatment breakdown at the clinic level possibly due to limited staff; and initiating ART only once one feels physically ill. Participants perceived social support as a buffer against stigma and facilitator of HIV treatment. Some clients also reported that persistent monitoring and follow-up on their HIV care and treatment by methadone clinic providers led them to initiate ART. CONCLUSION: Health system factors, stigma and limited social support pose challenges for methadone clients living with HIV to initiate ART. Our findings suggest that on-site point-of-care CD4 testing, a peer support system, and trained HIV treatment specialists who are able to counsel HIV-positive clients and initiate them on ART at the methadone clinic could help reduce barriers to timely ART initiation for methadone clients.
BACKGROUND: Despite dramatic improvement in antiretroviral therapy (ART) access globally, people living with HIV who inject drugs continue to face barriers that limit their access to treatment. This paper explores barriers and facilitators to ART initiation among clients attending a methadone clinic in Dar es Salaam, Tanzania. METHODS: We interviewed 12 providers and 20 clients living with HIV at the Muhimbili National Hospital methadone clinic between January and February 2015. We purposively sampled clients based on sex and ART status and providers based on job function. To analyze interview transcripts, we adopted a content analysis approach. RESULTS:Participants identified several factors that hindered timely ART initiation for clients at the methadone clinic. These included delays in CD4 testing and receiving CD4 test results; off-site HIV clinics; stigma operating at the individual, social and institutional levels; insufficient knowledge of the benefits of early ART initiation among clients; treatment breakdown at the clinic level possibly due to limited staff; and initiating ART only once one feels physically ill. Participants perceived social support as a buffer against stigma and facilitator of HIV treatment. Some clients also reported that persistent monitoring and follow-up on their HIV care and treatment by methadone clinic providers led them to initiate ART. CONCLUSION: Health system factors, stigma and limited social support pose challenges for methadone clients living with HIV to initiate ART. Our findings suggest that on-site point-of-care CD4 testing, a peer support system, and trained HIV treatment specialists who are able to counsel HIV-positive clients and initiate them on ART at the methadone clinic could help reduce barriers to timely ART initiation for methadone clients.
Authors: Sheryl A McCurdy; Michael W Ross; Gad Paul Kilonzo; M T Leshabari; Mark L Williams Journal: Drug Alcohol Depend Date: 2006-04 Impact factor: 4.492
Authors: Megha Ramaswamy; Patricia J Kelly; Xuan Li; Karina M Berg; Alain H Litwin; Julia H Arnsten Journal: J Assoc Nurses AIDS Care Date: 2012-08-04 Impact factor: 1.354
Authors: Monica da Silva; Meridith Blevins; C William Wester; José Manjolo; Eurico José; Lazaro C Gonzalez; Bryan E Shepherd; Troy D Moon; Lara M E Vaz Journal: AIDS Behav Date: 2015-04
Authors: Barrot H Lambdin; Ben Cheng; Trevor Peter; Jessie Mbwambo; Tsitsi Apollo; Megan Dunbar; Ifeoma C Udoh; Adithya Cattamanchi; Elvin H Geng; Paul Volberding Journal: Curr HIV Res Date: 2015 Impact factor: 1.581
Authors: Saria Hassan; Alexis Cooke; Haneefa Saleem; Dorothy Mushi; Jessie Mbwambo; Barrot H Lambdin Journal: Int J Environ Res Public Health Date: 2019-02-28 Impact factor: 3.390
Authors: Aida Roziana Ramlan; Nor Ilyani Mohamed Nazar; Afidalina Tumian; Norny Syafinaz Ab Rahman; Dzawani Mohamad; Mat Sharil Abdul Talib; Khairul Faizan M Zakaria; Muhammad Azzim Izuddin; Nadia Akmal Zainal Abidin; Syarifah Syafiqah T Syed Manso; Wan Nur Khairiyah Wan Hassan Journal: J Pharm Bioallied Sci Date: 2020-11-05
Authors: Julia Dickson-Gomez; Sarah Krechel; Dan Katende; Bryan Johnston; Wamala Twaibu; Laura Glasman; Moses Ogwal; Geofrey Musinguzi Journal: Int J Environ Res Public Health Date: 2022-08-20 Impact factor: 4.614